日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The association between appendicular skeletal muscle index and liver steatosis and fibrosis: A cross-sectional study

四肢骨骼肌指数与肝脂肪变性和纤维化的关系：一项横断面研究

期刊:Caspian Journal of Internal Medicine
影响因子:1
doi:10.22088/cjim.17.1.113
Basham, Ayoub; Teshnizi, Saeed Hosseini; Evazi, Ebrahim; Alavian, Seyed Moayed; Khajehpour, Alireza; Razmpour, Farkhondeh
发表日期：2026
文献求助 收藏

Hepatitis B virus infection after immunization: How serious it is? An updated review

接种疫苗后感染乙型肝炎病毒：严重程度如何？最新综述

期刊:Clinical and Experimental Medicine
影响因子:3.5
doi:10.1007/s10238-025-01645-8
Marjani, Arezoo; Alavian, Seyed Moayed; Nassiri Toosi, Mohssen; Alavian, Seyed Hoda; Abazari, Mohammad Foad; Khamseh, Azam; Jazayeri, Seyed Mohammad
炎症/感染
肝炎
微生物学
发表日期：2025
文献求助 收藏

A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran

伊朗丙型肝炎治疗中格卡瑞韦/哌仑他韦与索非布韦/达克拉他韦和索非布韦/维帕他韦的成本效用分析

期刊:
影响因子:
doi:10.1186/s12962-025-00656-2
Jafari, Mojtaba; Mehdizadeh, Parisa; Keshavarz, Khosro; Teymourzadeh, Ehsan; Abyazi, Mohammad Ali; Alavian, Seyed Moayed; Pouria, Alijanpour
肝炎
发表日期：2025
文献求助 收藏

Economic evaluations of Glecaprevir/Pibrentasvir and Grazoprevir/Elbasvir for the treatment of hepatitis C: a systematic review

格卡瑞韦/哌仑他韦和格拉瑞韦/艾尔巴韦治疗丙型肝炎的经济学评价：系统评价

期刊:
影响因子:
doi:10.1186/s12962-025-00700-1
Jafari, Mojtaba; Mehdizadeh, Parisa; Teymourzadeh, Ehsan; Salesi, Mahmood; Keshavarz, Khosro; Abyazi, Mohammad Ali; Heiat, Mohammad; Alavian, Seyed Moayed
肝炎
发表日期：2025
文献求助 收藏

Evaluation of autoimmune liver disease natural history in patients referred to Middle East Liver Diseases (MELD) center

对转诊至中东肝病（MELD）中心的自身免疫性肝病患者的自然病程进行评估

期刊:BMC Gastroenterology
影响因子:2.6
doi:10.1186/s12876-023-03105-7
Nejad, Seyed Erfan Mehdi; Heiat, Mohammad; Javanbakht, Mohammad; Alavian, Seyed Moayed; Haris, Mohammad Ali Abyazi
免疫/内分泌
发表日期：2024
文献求助 收藏

Effect of a moderately carbohydrate-restricted diet on liver enzymes, steatosis and fibrosis in normal-weight individuals with non-alcoholic fatty liver disease: study protocol for a parallel randomised controlled clinical trial

适度限制碳水化合物饮食对正常体重非酒精性脂肪肝患者肝酶、脂肪变性和纤维化的影响：一项平行随机对照临床试验的研究方案

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2022-063988
Dashti, Fatemeh; Alavian, Seyed Moayed; Sohrabpour, Amir Ali; Mousavi, Sara Ebrahimi; Keshavarz, Seyed-Ali; Esmaillzadeh, Ahmad
代谢
脂肪肝
发表日期：2023
文献求助 收藏

The effect of daily consumption of probiotic yogurt on liver enzymes, steatosis and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized clinical trial

益生菌酸奶每日摄入对非酒精性脂肪性肝病（NAFLD）患者肝酶、脂肪变性和纤维化的影响：一项随机临床试验的研究方案

期刊:BMC Gastroenterology
影响因子:2.6
doi:10.1186/s12876-022-02176-2
Ebrahimi-Mousavi, Sara; Alavian, Seyed Moayed; Sohrabpour, Amir Ali; Dashti, Fatemeh; Djafarian, Kurosh; Esmaillzadeh, Ahmad
脂肪肝
发表日期：2022
文献求助 收藏

Immunotoxins Immunotherapy against Hepatocellular Carcinoma: A Promising Prospect

免疫毒素在肝细胞癌免疫疗法中的应用：前景广阔

期刊:Toxins
影响因子:4
doi:10.3390/toxins13100719
Heiat, Mohammad; Hashemi Yeganeh, Hamid; Alavian, Seyed Moayed; Rezaie, Ehsan
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2021
文献求助 收藏

DT389-YP7, a Recombinant Immunotoxin against Glypican-3 That Inhibits Hepatocellular Cancer Cells: An In Vitro Study

DT389-YP7，一种针对糖蛋白聚糖-3的重组免疫毒素，可抑制肝细胞癌细胞：一项体外研究

期刊:Toxins
影响因子:4
doi:10.3390/toxins13110749
Hashemi Yeganeh, Hamid; Heiat, Mohammad; Kieliszek, Marek; Alavian, Seyed Moayed; Rezaie, Ehsan
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2021
文献求助 收藏

Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis

伊朗注射吸毒者（PWID）中危害降低计划与丙型肝炎流行情况：最新系统评价和累积荟萃分析

期刊:Harm Reduction Journal
影响因子:4
doi:10.1186/s12954-020-00441-9
Rajabi, Abdolhalim; Sharafi, Heidar; Alavian, Seyed Moayed
肝炎
发表日期：2021
文献求助 收藏